Additional file 3: of Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Authors :: LoĂŻc Lebellec
FranĂ§Ois Bertucci
Tresch-Bruneel, Emmanuelle
Ray-Coquard, Isabelle
Cesne, Axel Le
Bompas, Emmanuelle
Jean-Yves Blay
Italiano, Antoine
Mir, Olivier
Ryckewaert, Thomas
Toiron, Yves
Camoin, Luc
Goncalves, Anthony
Penel, Nicolas
Marie-CĂŠcile Le Deley
Publication Year :: 2018
Publisher :: figshare, 2018.
Abstract: Figure S2. Baseline biomarker values according to medical history (de novo versus radio-induced angiosarcoma). (PPTX 290 kb)

Full Text Access

Tools